Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    12 April 2024

    Bio-Rad announces collaboration agreement with Oncocyte to commercialize transplant monitoring with Droplet Digital PCR

    Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational Monitoring of Key Biomarkers in Solid Tissue Transplants HERCULES, Calif.— April 12, 2024 — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, a...

    15 April 2024

    Guardtech land Medilink Midlands Business Awards Innovation nomination with CleanCube

    The Group’s unique portable container laboratories will be up for the gong at Medilink’s Athena Leicester showpiece next month ...

    15 April 2024

    Onwards and upwards for expression edits

    The Epicentre, Haverhill spoke to Chief Operating Officer Dr Rebecca Godfrey about how ExpresionEdits was started, what it is currently working on and how its experience at The EpiCentre has helped it grow the business and move on to the next phase of its expansion. ...

    11 April 2024

    SPT Labtech appoints Rob Walton as New Chief Executive Officer

    Melbourn, UK, 11 April 2024 —

    11 April 2024

    Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries

    Access to compound collection enables greater flexibility and efficiencies in screening and target identification Cambridge, UK and Kyiv, Ukraine, 11 April 2024: Metrion Biosciences Limited, the specialist ion channel and cardiac safety screening contract research organisation (CRO) an...

    10 April 2024

    Preci and Biopredic International partner for higher performance of suspended pooled hepatocytes with extended longevity and large-scale availability

    License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME studies ...

    9 April 2024

    Have you heard about Carers Leave?

    From 6 April 2024 all unpaid carers are entitled to up to a week's unpaid leave per year to look after someone with a disability or long-term illness. But don't panic! We are here to help :-) ...

    9 April 2024

    Understanding and managing Interstitial Lung Disease

    Interstitial lung disease (ILD) is an umbrella term used to describe a group of highly variable restrictive lung diseases, which are characterised by inflammation and pulmonary fibrosis (scarring of the lungs). These diseases primarily affect the lung interstitium, the tissue and the sp...

    9 April 2024

    Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalised monitoring of solid tumor cancers with Droplet Digital PCR

    Collaboration aims to grow clinical evidence supporting the use of Bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types. ...

    14 March 2024

    Access solutions: Reconciling potential for improved patient access with implementation realities

    Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical companies can play a key role in tackling this issue through innovative solutions, varying from short-term payment agreements to comp...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 140
    • Page 141
    • Current page 142
    • Page 143
    • Page 144
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS